The downgrade is based on a number of factors, including OVGH’s large operating losses, negative cash flow and significant recent liquidity declines.
The outlook is negative, reflecting OVGH’s risks of breaching a covenant and debt acceleration or further liquidity decline if operating losses continue at the current pace.
More articles on healthcare finance:
Beauty retailer replaces Tenet on S&P 500
ADR limits & denials: 4 observations from Craneware’s Jeff St. Vrain
Jefferson’s neuroscience institute gets boost with $20M donation
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
